New Advances in Chemical Research in 2021. In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 59564-59-9, name is 3,4-Dihydroquinoxalin-2(1H)-one, introducing its new discovery. Related Products of 59564-59-9
The present invention provides compounds of formula I and pharmaceutically acceptable salts thereof.The formula I compounds inhibit the tyrosine kinase activity of growth factor receptors such as VEGFR-2, FGFR-1, PDGFR, HER-1, HER-2, thereby making them useful as anti-cancer agents. The formula I compounds are also useful for the treatment of other diseases associated with signal transduction pathways operating through growth factor receptors.
Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.Related Products of 59564-59-9. In my other articles, you can also check out more blogs about 59564-59-9
Reference：
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N135 | ChemSpider